ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Eur J Med Chem. 2018 Sep 5;157:1276-1291. doi: 10.1016/j.ejmech.2018.09.001. Epub 2018 Sep 1.
Eur J Med Chem. 2018.
PMID: 30195238
Review.